Literature DB >> 22138907

Cancer: CRC screening--cost effectiveness of fecal immunochemical tests.

Celia Berchi, Guy Launoy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22138907     DOI： 10.1038/nrgastro.2011.198

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  5 in total

1.  The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening.

Authors:  F Loeve; R Boer; G J van Oortmarssen; M van Ballegooijen; J D Habbema
Journal:  Comput Biomed Res       Date:  1999-02

2.  Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening.

Authors:  Janneke A Wilschut; Lieke Hol; Evelien Dekker; Jan B Jansen; Monique E Van Leerdam; Iris Lansdorp-Vogelaar; Ernst J Kuipers; J Dik F Habbema; Marjolein Van Ballegooijen
Journal:  Gastroenterology       Date:  2011-07-22       Impact factor: 22.682

3.  Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).

Authors:  Li-Sheng Chen; Chao-Sheng Liao; Shu-Hui Chang; Hsin-Chih Lai; Tony Hsiu-Hsi Chen
Journal:  J Med Screen       Date:  2007       Impact factor: 2.136

4.  As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia.

Authors:  M Parekh; A M Fendrick; U Ladabaum
Journal:  Aliment Pharmacol Ther       Date:  2008-01-29       Impact factor: 8.171

Review 5.  Cost-effectiveness of colorectal cancer screening.

Authors:  Iris Lansdorp-Vogelaar; Amy B Knudsen; Hermann Brenner
Journal:  Epidemiol Rev       Date:  2011-06-01       Impact factor: 6.222
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.